ErbB2, alternatively referred to as HER2, represents a transmembrane glycoprotein belonging to the ErbB family of proteins, distinctly acknowledged as an oncogene commonly overexpressed in breast cancer [18, 137]. This evidence concerns the gene EGFR and breast carcinoma.